New Nordic Healthbrands AB (publ) (NNH.ST)
SEK 14.6
(-3.31%)
SEK 14.6
(-3.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 28.02 Million | -15.45 Million | -7.87 Million | 19.68 Million | -667 Thousand | 17.85 Million |
| Net Income | -6.19 Million | -4.74 Million | 28.54 Million | 23.84 Million | 36.3 Million | 34.22 Million |
| Depreciation & Amortization | 1.89 Million | 1.64 Million | 935 Thousand | 753 Thousand | 560 Thousand | 668 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 31.67 Million | -3.36 Million | -31.13 Million | 4.58 Million | -31.12 Million | -11.98 Million |
| Other non-cash items | 648 Thousand | -8.98 Million | -6.21 Million | -9.5 Million | -6.4 Million | -5.05 Million |
| Investing Cash Flow | -3.39 Million | -2.61 Million | -2.97 Million | -1.16 Million | -1.74 Million | -536 Thousand |
| Investments in PPE | -2.14 Million | -2.95 Million | -2.71 Million | -1.88 Million | -1.68 Million | -880 Thousand |
| Acquisitions | - | 287 Thousand | - | - | - | 231 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 292 Thousand | - |
| Other Investing Activities | -1.25 Million | 48 Thousand | -261 Thousand | 713 Thousand | -351 Thousand | 344 Thousand |
| Financing Cash Flow | -21.17 Million | 16.58 Million | 12.07 Million | -18.39 Million | -1.24 Million | -11.97 Million |
| Debt repayment | -21.17 Million | -24.33 Million | -22.86 Million | -7.55 Million | -8.04 Million | -214 Thousand |
| Dividends payments | - | -7.74 Million | -9.29 Million | -10.84 Million | -9.29 Million | -7.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -21.17 Million | 48.66 Million | 44.22 Million | 858 Thousand | 16.08 Million | -4.63 Million |
| Accounts receivables | 2.75 Million | -10.44 Million | -4.61 Million | 6.1 Million | -21.19 Million | -4.76 Million |
| Accounts payables | 24.01 Million | 786 Thousand | 9.27 Million | -1.23 Million | 5.32 Million | 6.98 Million |
| Inventory | 4.91 Million | 6.29 Million | -35.78 Million | -280 Thousand | -15.26 Million | -14.2 Million |
| Other working capital | 24.01 Million | 786 Thousand | 9.27 Million | -1.23 Million | 5.32 Million | 2.22 Million |
| Cash at beginning of period | 10.7 Million | 11.88 Million | 10.4 Million | 10.81 Million | 14.38 Million | 9.05 Million |
| Cash at end of period | 13.81 Million | 10.7 Million | 11.88 Million | 10.4 Million | 10.81 Million | 14.38 Million |
| Capital Expenditure | -2.14 Million | -2.95 Million | -2.71 Million | -1.88 Million | -1.68 Million | -880 Thousand |
| Effect of forex changes on cash | -349 Thousand | 300 Thousand | 250 Thousand | -533 Thousand | 92 Thousand | -15 Thousand |
| Net cash flow / Change in cash | 3.11 Million | -1.18 Million | 1.48 Million | -415 Thousand | -3.56 Million | 5.32 Million |
| Free Cash Flow | 25.88 Million | -18.4 Million | -10.58 Million | 17.79 Million | -2.35 Million | 16.97 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.76 Million | -4.47 Million | -3.38 Million | -5.71 Million | -6.19 Million | 3.12 Million |
| Depreciation & Amortization | 563 Thousand | 533 Thousand | 502 Thousand | 730 Thousand | 1.22 Million | 405 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 556 Thousand | 2.14 Million | -10.92 Million | 11.87 Million | 31.67 Million | 1.76 Million |
| Other non-cash items | -208 Thousand | 682 Thousand | 9.99 Million | -7.42 Million | -27.91 Million | -5.53 Million |
| Investing Cash Flow | -2.73 Million | -186 Thousand | -620 Thousand | -2.11 Million | -3.39 Million | -127 Thousand |
| Investments in PPE | -254 Thousand | -184 Thousand | -1.06 Million | -1.52 Million | -3.06 Million | -394 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3000.00 | -2000.00 | 446 Thousand | -589 Thousand | -330 Thousand | 267 Thousand |
| Financing Cash Flow | 1.97 Million | 2.4 Million | 12.22 Million | -7.11 Million | -21.17 Million | -2.19 Million |
| Debt repayment | -1.97 Million | -3.31 Million | -12.22 Million | -7.11 Million | -21.17 Million | -2.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1000.00 | -905 Thousand | 85 Thousand | -7.11 Million | -21.17 Million | 14 Thousand |
| Accounts receivables | 11.49 Million | 2.17 Million | -6.85 Million | 18.57 Million | 2.75 Million | -8.29 Million |
| Accounts payables | -15.63 Million | -88 Thousand | -1.85 Million | 2.51 Million | 24.01 Million | 8.31 Million |
| Inventory | 4.7 Million | 59 Thousand | -2.22 Million | -9.21 Million | 4.91 Million | 1.74 Million |
| Other working capital | - | -88 Thousand | -1.85 Million | 2.51 Million | 24.01 Million | 1.00 |
| Cash at beginning of period | 11.86 Million | 9.86 Million | 13.81 Million | 13.6 Million | 10.7 Million | 16.57 Million |
| Cash at end of period | 10.1 Million | 11.86 Million | 9.86 Million | 13.81 Million | 13.81 Million | 13.6 Million |
| Capital Expenditure | -254 Thousand | -184 Thousand | -1.06 Million | -1.52 Million | -3.06 Million | -394 Thousand |
| Effect of forex changes on cash | - | -177 Thousand | 205 Thousand | -439 Thousand | -349 Thousand | -410 Thousand |
| Net cash flow / Change in cash | -1.76 Million | 2 Million | -3.94 Million | 211 Thousand | 3.11 Million | -2.97 Million |
| Free Cash Flow | -1.1 Million | -226 Thousand | -16.82 Million | 8.35 Million | 24.96 Million | -640 Thousand |
000591
LUC
002650
RFLXF
LLN
DTCFF